|
US2009081683A1
|
|
Kits and Methods for Assessing the Coenzyme Q Reducing Status of a Patient, Including a Patient Ingesting a Statin
|
|
US2008311587A1
|
|
Use of Genetic Information to Detect a Predisposition for Bone Density Conditions
|
|
WO2007064674A2
|
|
Methods for assessing the coenzyme q reducing status of a patient
|
|
WO2006104991A2
|
|
Kits and methods for assessing antioxidant requirement of a human
|
|
US2003073612A1
|
|
Kits and methods for assessing skin health
|
|
US2004005566A1
|
|
Kits and methods for assessing cardiovascular health
|
|
AU2002315165A1
|
|
Kits and methods for assessing leptin-mediated lipid matabolism
|
|
AU2002309543B2
|
|
Kits and methods for assessing oxidative stress
|
|
US2004121320A1
|
|
Use of genetic information to detect a predisposition for bone density conditions
|
|
US2002146698A1
|
|
Kits and methods for assessing oxidative stress
|
|
JP2000232982A
|
|
Noninvasive identification system
|
|
WO9718009A1
|
|
Non-invasive identification system
|
